Lupin shares fall 2.06% in early trade on Nifty Midcap 150, among top midcap losers

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Shares of Lupin declined 2.06% to Rs 1,889.40 in Friday's session, with trading commencing at 09:15 am on the NSE. The stock is among the top losers on the Nifty Midcap 150.

Regarding Lupin's consolidated quarterly financial performance, the revenue for the quarter-ending March 2025 stood at Rs 5,667.13 Crore. This represents a decrease compared to the quarter-ending December 2024, where the revenue was Rs 5,767.71 Crore. The net profit for the quarter-ending March 2025 was Rs 782.38 Crore, and the earnings per share (EPS) was Rs 16.93.

A detailed look at Lupin's consolidated quarterly financials:

The company's consolidated yearly financial performance shows a positive growth trend. Revenue for the year-ending March 2025 reached Rs 22,707.90 Crore, an increase compared to Rs 20,010.82 Crore for the year-ending March 2024. The net profit for the year-ending March 2025 stood at Rs 3,306.26 Crore, significantly higher than the Rs 1,935.57 Crore reported for the year-ending March 2024. The EPS for March 2025 was Rs 71.95, compared to Rs 42.05 for March 2024.

Summary of Lupin's consolidated yearly financials:

Lupin's standalone annual income statement reveals sales of Rs 16,967 Crore for March 2025, a notable increase from Rs 14,666 Crore for March 2024. This represents a growth of approximately 15.69%. The net profit for the same period stood at Rs 3,972 Crore, compared to Rs 2,326 Crore for March 2024, highlighting a substantial increase in profitability. The total income for March 2025 was Rs 17,141 Crore.

Key figures from Lupin's standalone annual income statement:

Lupin's standalone quarterly income statement indicates sales of Rs 4,485 Crore for March 2025, compared to Rs 3,395 Crore for March 2024. This represents a significant increase of approximately 32.11%. The net profit for the same period stood at Rs 1,291 Crore, substantially higher than the Rs 384 Crore reported in March 2024. The total income for March 2025 was Rs 4,534 Crore.

Summary of Lupin's standalone quarterly financials:

The cash flow statement indicates a net cash flow of Rs 218 Crore for March 2025, compared to Rs -990 Crore in March 2021. Cash flow from operating activities was Rs 2,444 Crore, while cash flow from investing activities was Rs -1,766 Crore.

Key highlights from the cash flow statement:

The balance sheet for March 2025 shows total assets of Rs 28,431 Crore, with fixed assets at Rs 5,224 Crore and current assets at Rs 11,894 Crore. Total liabilities amounted to Rs 28,431 Crore, with share capital at Rs 91 Crore and reserves & surplus at Rs 24,186 Crore.

Key figures from the balance sheet:

Key financial ratios reveal a basic EPS of Rs 87.10 for March 2025, compared to Rs 27.77 in March 2021. The debt-to-equity ratio for March 2025 is 0.00. The P/E ratio stood at 23.28, while the P/B ratio was 3.81.

Key financial ratios:

The company announced a final dividend of Rs 12 per share (600%) on May 14, 2025, effective July 25, 2025. Other corporate actions include analyst/investor meets and press releases regarding US FDA approvals for Liraglutide and Glucagon injectable products.

At 09:25 am on Friday, Lupin is trading at Rs 1,889.40, a decrease of 2.06%.